Our in vitro and in vivo results, including kidney tumor patient samples, showed loss of PBRM1 in ccRCC dampened p53 function and especially p21 expression, which is key for cell cycle arrest and senescence. Here, PBRM1 is linked to nonpapillary renal cell carcinoma.